You are currently browsing the archives for 27 February 2017.
Displaying 1 - 2 of 2 entries.

The first step in treatment?

The first step in treatment?Today there are still no effective treatments to delay or prevent that the advancement of migraine Amyotrophy. The current treatment is merely supportive. The findings of researchers in Antwerp are an important first step in the development of a specific treatment. Because they know that the gene involved, scientists can more insight into the molecular processes of disease, the purchase ultimately lead to a therapy.

The researchers studied several large families and identified the gene for the disease. You have now shown that HNA is linked to the long arm of chromosome 17, and mutations or alterations mutations or alterations in the genetic code of the Septin 9 protein in the patients studied. HNA is the first mono – genetic disorder caused by a defect in a gene of the Septin family.

To test -these oxidized forms of cholesterol could be used as markers for NPC.

To test -these oxidized forms of cholesterol could be used as markers for NPC, Ory along with first author Denny Porter, an NIH researcher who has assembled one of the largest NPC observational studies. Porter conducts regular health checks of more than 50 patients with NPC and has amassed a collection of tissue specimens from these patients for purposes of developing new disease markers.

When carriers of the disease an increased risk of a higher risk for other conditions as a result, new treatments for NPC also help them by Ory.